Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis

Psychiatry Research - Neuroimaging

Volumn 233, Issue 3, 2015, Pages 481-487

  Watanabe, Keita ^a   Kakeda, Shingo ^a   Yoshimura, Reiji ^a   Abe, Osamu ^b   Ide, Satoru ^a   Hayashi, Kenji ^a   Katsuki, Asuka ^a   Umene Nakano, Wakako ^a   Watanabe, Rieko ^a   Nakamura, Jun ^a   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Caudate; Major depressive disorder; Val108 158Met COMT; VBM

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE; COMT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IMAGE PROCESSING; MAJOR DEPRESSION; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; VOXEL BASED MORPHOMETRY; BRAIN; BRAIN MAPPING; CAUDATE NUCLEUS; DEPRESSIVE DISORDER, MAJOR; GENETICS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AGED; BRAIN; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; CAUDATE NUCLEUS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; VALINE; YOUNG ADULT;

EID: 84952636859     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2015.07.024     Document Type: Article

References (52)

1. Akil M., Kolachana B.S., Rothmond D.A., Hyde T.M., Weinberger D.R., Kleinman J.E. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J. Neurosci. 2003, 23:2008-2013.
2. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
3. Ashburner J. Computational anatomy with the SPM software. Magn. Reson. Imaging 2009, 27:1163-1174.
4. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImage 2000, 11:805-821.
5. Barnes J., Ridgway G.R., Bartlett J., Henley S.M., Lehmann M., Hobbs N., Clarkson M.J., MacManus D.G., Ourselin S., Fox N.C. Head size, age and gender adjustment in MRI studies: a necessary nuisance?. NeuroImage 2010, 53:1244-1255.
6. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Goodman J.M., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 1997, 19:591-611.
7. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 2000, 20:3864-3873.
8. Chumbley J., Worsley K., Flandin G., Friston K. Topological FDR for neuroimaging. NeuroImage 2010, 49:3057-3064.
9. Chumbley J.R., Friston K.J. False discovery rate revisited: FDR and topological inference using Gaussian random fields. NeuroImage 2009, 44:62-70.
10. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am. J. Med. Genet. 2002, 114:380-390.
11. Delgado y Palacios R., Verhoye M., Henningsen K., Wiborg O., Van der Linden A. Diffusion kurtosis imaging and high-resolution MRI demonstrate structural aberrations of caudate putamen and amygdala after chronic mild stress. PloS One 2014, 9:e95077.
12. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry 2000, 48:813-829.
13. Ehrlich S., Morrow E.M., Roffman J.L., Wallace S.R., Naylor M., Bockholt H.J., Lundquist A., Yendiki A., Ho B.C., White T., Manoach D.S., Clark V.P., Calhoun V.D., Gollub R.L., Holt D.J. The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults. NeuroImage 2010, 53:992-1000.
14. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
15. Frisch A., Postilnick D., Rockah R., Michaelovsky E., Postilnick S., Birman E., Laor N., Rauchverger B., Kreinin A., Poyurovsky M., Schneidman M., Modai I., Weizman R. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 1999, 4:389-392.
16. Gabbay V., Hess D.A., Liu S., Babb J.S., Klein R.G., Gonen O. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study. Am. J. Psychiatry 2007, 164:1881-1889.
17. Grossman M.H., Emanuel B.S., Budarf M.L. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 1992, 12:822-825.
18. Hamilton J.P., Siemer M., Gotlib I.H. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol. Psychiatry 2008, 13:993-1000.
19. Hasler G., Drevets W.C., Manji H.K., Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004, 29:1765-1781.
20. Hayashi K., Yoshimura R., Kakeda S., Kishi T., Abe O., Umene-Nakano W., Katsuki A., Hori H., Ikenouchi-Sugita A., Watanabe K., Ide S., Ueda I., Moriya J., Iwata N., Korogi Y., Kubicki M., Nakamura J. COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naive major depressive disorder: a diffusion tensor imaging study. Neuropsychiatr. Dis. Treat. 2014, 10:1183-1190.
21. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., Macfall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. NeuroImage 2006, 30:436-443.
22. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 1999, 156:837-841.
23. Krugel L.K., Biele G., Mohr P.N., Li S.C., Heekeren H.R. Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions. Proc. Natl. Acad. Sci. USA 2009, 106:17951-17956.
24. Kunugi H., Vallada H.P., Hoda F., Kirov G., Gill M., Aitchison K.J., Ball D., Arranz M.J., Murray R.M., Collier D.A. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biol. Psychiatry 1997, 42:282-285.
25. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
26. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain Mapp. 2000, 10:120-131.
27. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
28. Maldjian J.A., Laurienti P.J., Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. NeuroImage 2004, 21:450-455.
29. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19:1233-1239.
30. Marchand W.R. Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disorders. Brain Struct. Funct. 2010, 215:73-96.
31. Massat I., Souery D., Del-Favero J., Nothen M., Blackwood D., Muir W., Kaneva R., Serretti A., Lorenzi C., Rietschel M., Milanova V., Papadimitriou G.N., Dikeos D., Van Broekhoven C., Mendlewicz J. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 2005, 10:598-605.
32. Matsumoto M., Weickert C.S., Beltaifa S., Kolachana B., Chen J., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003, 28:1521-1530.
33. McEwen B.S. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann. N. Y. Acad. Sci. 2010, 1204(Suppl):E38-E59.
34. Meyer-Lindenberg A., Kohn P.D., Kolachana B., Kippenhan S., McInerney-Leo A., Nussbaum R., Weinberger D.R., Berman K.F. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci. 2005, 8:594-596.
35. Meyer J.H., Kruger S., Wilson A.A., Christensen B.K., Goulding V.S., Schaffer A., Minifie C., Houle S., Hussey D., Kennedy S.H. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 2001, 12:4121-4125.
36. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
37. Nutt D.J., Baldwin D.S., Clayton A.H., Elgie R., Lecrubier Y., Montejo A.L., Papakostas G.I., Souery D., Trivedi M.H., Tylee A. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J. Clin. Psychiatry 2006, 67(Suppl 6):46-49.
38. Ohnishi T., Hashimoto R., Mori T., Nemoto K., Moriguchi Y., Iida H., Noguchi H., Nakabayashi T., Hori H., Ohmori M., Tsukue R., Anami K., Hirabayashi N., Harada S., Arima K., Saitoh O., Kunugi H. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006, 129:399-410.
39. Opmeer E.M., Kortekaas R., van Tol M.J., van der Wee N.J., Woudstra S., van Buchem M.A., Penninx B.W., Veltman D.J., Aleman A. Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory. PloS One 2013, 8:e73290.
40. Pan C.C., McQuoid D.R., Taylor W.D., Payne M.E., Ashley-Koch A., Steffens D.C. Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen. Int. J. Geriatr. Psychiatry 2009, 24:847-855.
41. Parashos I.A., Tupler L.A., Blitchington T., Krishnan K.R. Magnetic-resonance morphometry in patients with major depression. Psychiatry Res.: Neuroimaging 1998, 84:7-15.
42. Seok J.H., Choi S., Lim H.K., Lee S.H., Kim I., Ham B.J. Effect of the COMT val158met polymorphism on white matter connectivity in patients with major depressive disorder. Neurosci. Lett. 2013, 545:35-39.
43. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
44. Takahata R., Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J. Neurochem. 2000, 75:1775-1778.
45. Tremblay L.K., Naranjo C.A., Graham S.J., Herrmann N., Mayberg H.S., Hevenor S., Busto U.E. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch. Gen. Psychiatry 2005, 62:1228-1236.
46. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
47. Vernaleken I., Weibrich C., Siessmeier T., Buchholz H.G., Rosch F., Heinz A., Cumming P., Stoeter P., Bartenstein P., Grunder G. Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age. NeuroImage 2007, 34:870-878.
48. Wagner G., Koch K., Schachtzabel C., Schultz C.C., Sauer H., Schlosser R.G. Structural brain alterations in patients with major depressive disorder and high risk for suicide: evidence for a distinct neurobiological entity?. NeuroImage 2011, 54:1607-1614.
49. Wahlstrom D., White T., Hooper C.J., Vrshek-Schallhorn S., Oetting W.S., Brott M.J., Luciana M. Variations in the catechol O-methyltransferase polymorphism and prefrontally guided behaviors in adolescents. Biol. Psychiatry 2007, 61:626-632.
50. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 1999, 39:19-52.
51. Xie T., Ho S.L., Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 1999, 56:31-38.
52. Zeng L.L., Liu L., Liu Y., Shen H., Li Y., Hu D. Antidepressant treatment normalizes white matter volume in patients with major depression. PloS One 2012, 7:e44248.